Similar articles

• [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].

  Sanz Ortiz J, Saiz García F. Sanz Ortiz J, et al. Med Clin (Barc). 1982 Nov 16-30;79(9):403-6. Med Clin (Barc). 1982. PMID: 6296560 Clinical Trial. Spanish. No abstract available.
• Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.

  Davis S, Pandya MR, Rambotti P. Davis S, et al. Cancer Treat Rep. 1980 Apr-May;64(4-5):685-8. Cancer Treat Rep. 1980. PMID: 6253067 Clinical Trial.
• Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.

  Pearlman NW, Meyers TJ, Siebert PE, Wallner SF, Carson SD, Campbell DN, Johnson FB, Kennaugh R, Rempel P. Pearlman NW, et al. Cancer Treat Rep. 1983 Apr;67(4):375-6. Cancer Treat Rep. 1983. PMID: 6303587
• [Chemotherapy of lung cancer].

  Dement'eva NP. Dement'eva NP. Sov Med. 1984;(11):55-61. Sov Med. 1984. PMID: 6084308 Review. Russian. No abstract available.
• The role of chemotherapy in the treatment of lung cancer.

  Selawry OS. Selawry OS. Semin Oncol. 1974 Sep;1(3):259-72. Semin Oncol. 1974. PMID: 4143488 Review. No abstract available.